Профиль Karolinska Development AB (B)
Karolinska Development AB engages in the investment in pharmaceutical business. It invests in companies that develop medical innovations, specialty care products and orphan drugs for patients suffering from life-threatening and serious debilitating conditions. Its funds are obtained from independent investors and shareholders by issuing and selling shares and interest-bearing instruments. The company was founded in 2006 and is headquartered in Solna, Sweden.